Related Experiment Videos
Photodynamic therapy for mesothelioma
S M Hahn1, R P Smith, J Friedberg
1Department of Radiation Oncology, University of Pennsylvania, 2 Donner, 3400 Spruce Street, Philadelphia, PA 19104-4283, USA. Hahn@xrt.upenn.edu
Current Treatment Options in Oncology
|June 12, 2002
Summary
Photodynamic therapy (PDT) is being investigated as an adjuvant treatment for malignant pleural mesothelioma. While promising for superficial tissues, current studies do not definitively prove PDT
Area of Science:
- Oncology
- Medical Physics
Background:
- Malignant pleural mesothelioma treatment remains challenging, with traditional therapies showing limited superiority over supportive care.
- Local recurrence is common, especially after surgery, highlighting the need for effective local therapies.
Purpose of the Study:
- To evaluate photodynamic therapy (PDT) as an adjuvant treatment for malignant pleural mesothelioma.
- To explore PDT's potential role after surgical debulking procedures.
Main Methods:
- Photodynamic therapy (PDT) involves a photosensitizing agent activated by specific light wavelengths.
- PDT's superficial treatment effect makes it theoretically suitable for body cavities and tissue surfaces post-surgery.
Main Results:
- Clinical studies have not conclusively demonstrated PDT's superiority over existing adjuvant therapies or surgery alone.
- Despite advancements in photosensitizers and laser technology, further research is required.
Conclusions:
- Photodynamic therapy (PDT) shows theoretical advantages for treating malignant pleural mesothelioma, particularly after surgery.
- Additional research is necessary to establish the definitive role and efficacy of PDT in mesothelioma management.